Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases
Practical Radiation Oncology · 2026
DOI: 10.1016/j.prro.2026.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Christopher B Jackson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Radiation Oncology. Electronic address: Jacksoc2@mskcc.org. Hauptthemen laut MEDLINE: Radiosurgery, Spinal Neoplasms, Re-Irradiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
PURPOSE: We sought to characterize outcomes from a large institutional database of patients treated with 3-fraction spine stereotactic body radiation therapy (SBRT) after prior overlapping radiation therapy. METHODS AND MATERIALS: The primary outcome of interest was local failure (LF) in the treated lesion, defined based on magnetic resonance imaging. We also characterized toxicities such as vertebral compression fracture and radiation myelitis. RESULTS: There were 83 patients treated to 87 spinal lesions between 2014 and 2023. Median follow-up was 14.2 (IQR, 6-29.4) months, and median overall survival was 20.5 (95% CI, 16.5-29.9) months. Most lesions were treated with 27 Gy in 3 fractions (n = 78; 90%). Most lesions had been treated with prior conventionally fractionated radiation therapy (59%), and the most common histology was prostate cancer (n = 15; 17%). The 1- and 2-year LF rate was 8.4% (95% CI, 3.7%-16%) and 15% (95% CI, 8.1%-24%), respectively. On univariable analysis, lower minimum dose to the planning target volume (hazard ratio, 0.85, 95% CI, 0.74-0.99, P = .03) and colorectal, cholangio-, or hepatocellular carcinoma histology (hazard ratio 5.6, 95% CI, 1.11-28.4, P = .037) were associated with risk of LF. There was 1 case of radiation myelitis (1.3%) and 5 cases (5.5%) of vertebral compression fracture. CONCLUSION: Reirradiation with spine SBRT in 3 fractions appears safe and is associated with a 2-year local control rate of 85%. Lower planning target volume, lower minimum dose, and gastrointestinal histology were associated with increased risk of LF. Further work is needed to identify the optimal dose-fractionation regimen for reirradiation with spine SBRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Radiation Oncology. Electronic address: Jacksoc2@mskcc.org.
- Medical Physics.
- Departments of Radiation Oncology.
- Orthopedic Surgery.
- Neurosurgery.
- Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Jackson, C. B., Zhang, L., Haseltine, J., Mueller, B. A., Schmitt, A. M., Vaynrub, M., Newman, W. C., Lis, E., Barzilai, O., Bilsky, M. H., Higginson, D. S., & Yamada, Y. (2026). Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2026.01.015
Vancouver
Jackson CB, Zhang L, Haseltine J, Mueller BA, Schmitt AM, Vaynrub M, et al. Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases. Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2026.01.015
BibTeX
@article{Jackson2026,
author = {Jackson, Christopher B and Zhang, Lei and Haseltine, Justin and Mueller, Boris A and Schmitt, Adam M and Vaynrub, Max and Newman, William C and Lis, Eric and Barzilai, Ori and Bilsky, Mark H and Higginson, Daniel S and Yamada, Yoshiya},
title = {Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases},
journal = {Practical Radiation Oncology},
year = {2026},
doi = {10.1016/j.prro.2026.01.015}
}
EUVIMED